Büyükkaya, RamazanKocaeli, HasanYıldırım, NalanCebeci, HakanErdoğan, CüneytHakyemez, Bahattin2020-04-302020-04-3020141591-01992385-2011https://doi.org/10.15274/INR-2014-10070https://hdl.handle.net/20.500.12684/5265WOS: 000349660300009PubMed: 25496683This study describes the pen-procedural and late complications and angiographic follow-up results of 32 patients with 34 complex aneurysms treated with flow diverter Silk stents in a single centre. In this retrospective study, 40 Silk stents (SS) were implanted in 34 complex intracranial aneurysms in 32 patients. In our series, 20 (58.8%) carotid-ophthalmic internal carotid artery (ICA), six (17.6%) cavernous ICA, two (5.9%) supraclinoid ICA, two (5.9%) petrosal ICA (the same patient-bilateral) and four (11.8%) posterior circulation aneurysms were treated. One of the posterior circulation lesions was a fenestrated-type aneurysm. Twenty wide-necked, saccular; eight neck remnant; four fusiform and two blister-like aneurysms were included in our series. SS were successfully implanted in all patients (100%). Mis-deployment occurred in 17.6% of patients. In two of these patients adequate stent openness was achieved via Hyperglide balloon dilatation. Coil embolization in addition to SS placement was utilized in four aneurysms. One patient (3%) experienced transient morbidity due to a thromboembolic event and there was one mortality (3%) due to remote intraparenchymal haemorrhage. Complete occlusion of 27/33 (81.8 %) and 29/33 (87.9 %) aneurysms was achieved six and 12 months after the procedure, respectively. In-stent intimal hyperplasia was detected in 6.1 % patients. Flow-diverter Silk stent implantation is an effective method of treating complex aneurysms with acceptable mortality and morbidity rates. Complete occlusion is achieved in most of the complex aneurysms.en10.15274/INR-2014-10070info:eu-repo/semantics/openAccesscerebral aneurysmsflow diverterSilk stentendovascular treatmentTreatment of Complex Intracranial Aneurysms Using Flow-Diverting Silk (R) Stents An Analysis of 32 Consecutive PatientsArticle206729735WOS:000349660300009Q2Q4